Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression is a research paper published in Science (2020). On theSindex it has a DataRank of 0. It has been cited 282 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 4R00CA178197-03
Dissecting stage-specific roles of TGF-beta in epidermal tumor progression
FWCI
13.03
Citation Percentile
1.0%
Influential Citations
7
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 2 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 1 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 2 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 3 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 3 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 4 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 4 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 5 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 5 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 6 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 6 of Identification of an immune-related signature indicating the dedifferentiation of thyroid cells
Additional file 12 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Additional file 12 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Additional file 13 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Additional file 13 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Additional file 4 of The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial–mesenchymal transition by phosphorylating β-catenin
Additional file 4 of The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial–mesenchymal transition by phosphorylating β-catenin
Additional file 9 of The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial–mesenchymal transition by phosphorylating β-catenin
Additional file 9 of The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial–mesenchymal transition by phosphorylating β-catenin